deltatrials
Recruiting NA INTERVENTIONAL 2-arm NCT06569160

Efficacy of Ultraviolet Germicidal Irradiation Devices to Reduce Respiratory Infections in Nursing Homes: Cluster Randomized Crossover Trial (RESPROTECT)

Impact du déploiement de Dispositifs d'Inactivation Des pathogènes de l'Air Par UVGI Dans la Lutte Contre Les Maladies Respiratoires Touchant Les résidents d'EHPAD

Sponsor: ANRS

Updated 4 times since 2024 Last updated: Dec 2, 2025 Started: Oct 1, 2024 Primary completion: Jun 1, 2026 Completion: Jun 1, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Acute Respiratory Infections and is currently actively recruiting participants. ANRS leads this study, which shows 4 recorded versions since 2024 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

~Sep 2024 – ~Jun 2025 · 9 months · monthly snapshotNot Yet Recruiting~Jun 2025 – ~Sep 2025 · 3 months · monthly snapshotRecruiting~Sep 2025 – ~Jan 2026 · 4 months · monthly snapshotRecruiting~Jan 2026 – present · 8 months · monthly snapshotRecruiting

Change History

4 versions recorded
  1. Jan 2026 — Present [monthly]

    Recruiting NA

  2. Sep 2025 — Jan 2026 [monthly]

    Recruiting NA

  3. Jun 2025 — Sep 2025 [monthly]

    Recruiting NA

    Status: Not Yet RecruitingRecruiting

  4. Sep 2024 — Jun 2025 [monthly]

    Not Yet Recruiting NA

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • ANRS
  • French National Research Agency on Emerging Infectious Diseases
  • Centre Hospitalier Emile Roux
Data source: Centre Hospitalier Emile Roux

For direct contact, visit the study record on ClinicalTrials.gov .